Metraipolis › archive › dc_4ffeffa7e1a4

Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer — Europe PMC PMID:42279380

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279380
DOI
10.3390/cancers18111799
License (as archived)
solo-consultazione
Archived
2026-11-01T00:26:15.289Z
SHA-256 of the archived text
59fb31ded8d18f6a4d9217d7f5779d635ba1634cbd17cc6a492dc2e9c1ad0f6d
Stable URL of this page
https://metraipolis.com/documento/dc_4ffeffa7e1a4

How to cite

Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer — Europe PMC PMID:42279380 — Europe PMC (en), https://europepmc.org/article/MED/42279380 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ffeffa7e1a4 (Metraipolis archive dc_4ffeffa7e1a4, sha256 59fb31ded8d18f6a4d9217d7f5779d635ba1634cbd17cc6a492dc2e9c1ad0f6d)
BibTeX
@misc{dc4ffeffa7e1a4,
  title = {Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer — Europe PMC PMID:42279380},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279380},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ffeffa7e1a4; sha256 59fb31ded8d18f6a4d9217d7f5779d635ba1634cbd17cc6a492dc2e9c1ad0f6d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279380. Agents can read the archived copy with the MCP tool read_document.